Puma Biotechnology, Inc. (PBYI)
5.955
+0.04
(+0.76%)
USD |
NASDAQ |
Dec 24, 12:59
5.955
0.00 (0.00%)
After-Hours: 13:59
Puma Biotechnology SG&A Expense (TTM): 69.09M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Nephros, Inc. | 8.556M |
| Sensus Healthcare, Inc. | 11.23M |
| ACADIA Pharmaceuticals, Inc. | 523.36M |
| Vanda Pharmaceuticals, Inc. | 214.26M |
| Vertex Pharmaceuticals, Inc. | 1.644B |